Kura Oncology Inc.
KURA | NASDAQ
$11.60
-$0.13 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$11.67
+$0.07 (+0.60%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $1.04B
Enterprise Value $535.21M
Beta 0.38
Average Volume 1.83M
Shares Outstanding (Diluted) 88.86M
Shares Change YoY 1.45%
Institutional Ownership 95.28%
Exchange NASDAQ
ISIN US50127T1097
Price Performance
Price Change 1M -2.0%
Price Change 3M 11.8%
Price Change 6M 35.7%
Price Change YTD 12.2%
Price Change 1Y 43.4%
Price Change 3Y 30.9%
Price Change 5Y -42.7%
1M CAGR (ann.) 26.4%
1Y CAGR (ann.) 45.0%
5Y CAGR (ann.) -10.7%
All-Time CAGR -2.2%
Valuation
PE Ratio -3.44
Forward PE N/A
PEG Ratio 0.09
Forward PEG 0.13
PS Ratio 13.33
Forward PS 4.90
PB Ratio 21.26
P/FCF Ratio -8.77
P/Adj. FCF Ratio -6.59
P/OCF Ratio -9.21
EV/Sales 6.93
EV/EBIT -1.81
EV/EBITDA -1.83
EV/FCF -4.56
Earnings Yield -29.1%
FCF Yield -11.4%
Adj. FCF Yield -15.2%
Financial Health
Net Cash $509.24M
Total Debt $24.46M
Cash & Short-Term Investments $519.03M
Total Assets $587.79M
Current Ratio 4.73
Quick Ratio 4.71
Debt / Equity Ratio 0.50
Debt / EBITDA -0.08
Debt / FCF -0.21
OCF / Debt -4.57
Interest Coverage -224.01
Altman Z-Score -2.60
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 94.7%
Operating Profit Margin -411.9%
EBITDA Margin -378.6%
Net Profit Margin -384.3%
FCF Margin -152.1%
Adj. FCF Margin -202.5%
SBC / Revenue 50.4%
SBC Impact (per share) -33.2%
Returns
Return on Assets -50.5%
Return on Equity -207.2%
Return on Invested Capital -67.0%
Return on Capital Employed -67.7%
Return on Tangible Assets -50.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 72.2%
Revenue CAGR 5Y 74.1%
Revenue CAGR 10Y 47.1%
EPS CAGR 3Y -21.8%
EPS CAGR 5Y -12.4%
EPS CAGR 10Y -7.7%
FCF CAGR 3Y 37.6%
FCF CAGR 5Y 29.8%
FCF CAGR 10Y -3.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 31.1%
Revenue Growth Next 3Y 85.5%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.84
EPS Growth Est (next Q) -1.2%
Revenue Est (next Q) $23.8M
Revenue Growth Est (next Q) 14.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $23.88
Price Target Upside 105.9%
Cash Flow
Operating Cash Flow $-111.76M
Free Cash Flow $-117.43M
Adj. Free Cash Flow $-156.37M
FCF Per Share -$1.32
OCF Per Share -$1.26
OCF/S Ratio -144.7%
Income Statement
Revenue $77.23M
Gross Profit $73.15M
Operating Income $-318.09M
EBITDA $-292.38M
Net Income $-296.78M
EPS (Diluted) -$3.37
Revenue / Employee $297.02K
Profit / Employee $-1.14M
Employees 260
Add to Watchlist
Select watchlists to add or remove KURA